Current Research in Pediatric Hematological Oncology

Dear Colleagues,

There has been remarkable progress in pediatric hematological oncology in recent years, driven by advances in genomics, immunology, and targeted therapies. Childhood cancers, including acute leukemias, myelodysplastic syndromes, and lymphomas, remain a significant cause of morbidity and mortality worldwide. Unlike adult malignancies, pediatric cancers are often driven by unique genetic and developmental mechanisms, underscoring the urgent need for specialized research approaches. Furthermore, survivorship challenges, late effects of therapy, and the need for precision medicine strategies highlight the importance of ongoing research in this field.

This Special Issue of Cancers, “Current Research in Pediatric Hematological Oncology”, will provide a platform for cutting-edge research and comprehensive reviews addressing the biology, diagnosis, and treatment of pediatric hematologic malignancies and related disorders. We particularly encourage studies that explore novel therapeutic strategies, the mechanisms behind disease progression, immunotherapy, resistance to treatment, and the use of innovative preclinical models. Additionally, contributions focusing on translational research, biomarker discovery, clinical trials, and supportive care are highly encouraged.

We welcome original research articles, reviews, and perspectives that advance our understanding of pediatric hematology-oncology and ultimately contribute to improving outcomes and quality of life for young patients.

Dr. Santhosh Kumar Pasupuleti
Dr. Tzu-Chieh Ho
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.